Pancreatic cancer early detection with blood test
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This trial studies a blood test to find pancreatic cancer early. It may help people who are at risk or have suspicious signs.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have an increased risk for pancreatic cancer or a condition that might be linked to it.
- You might have a type of cyst on your pancreas called IPMN.
- You do not have any other cancer right now.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new blood test that uses tiny particles and a laser to find signs of pancreatic cancer earlier. It may help people with pancreatic ductal adenocarcinoma (PDAC) or intraductal papillary mucinous neoplasms (IPMN), a type of cyst that can become cancer.
This study is testing a new blood test to find pancreatic cancer early. It looks for tiny bits of cancer DNA floating in your blood, which could help catch the disease before symptoms start.
This trial uses a blood test (called cfDNA) to look for early signs of pancreatic cancer. It compares results from people with pancreatic cancer, precancerous changes, non-cancerous pancreatic conditions, and healthy individuals to improve early detection.
This study looks at how certain substances in your blood and bacteria in your gut might help predict pancreatic cancer, especially in people with chronic pancreatitis. It aims to find early warning signs to catch cancer sooner.
This study looks at blood tests to find markers that may help detect and monitor pancreatic cancer. It compares people with pancreatic cancer to those with benign pancreatic conditions and healthy volunteers.
This trial uses a liquid biopsy (a simple blood test that looks for cancer DNA) to decide whether you should have chemotherapy before surgery or go straight to surgery. It is for people with pancreatic cancer that has not spread beyond the pancreas.
Hear when a new Pancreatic cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.